"Unlimited Organ Supply: The Potential of Genetically Modified Pigs for Human Transplants"
Biotech company Revivicor is at the forefront of using genetically modified cloned pigs to provide organs for transplants, aiming to alleviate the chronic shortage of organs for transplantation. The company's research has raised concerns about the ethics of using farm animals for their organs and the potential risks of spreading animal viruses to humans. Despite ethical concerns, Revivicor believes that breeding pigs for organ transplants serves a higher purpose than using them for meat and could save many lives. The company is conducting studies in baboons and human body donors to gather data for FDA approval to start formal human studies on the organ waiting list.